80
Participants
Start Date
October 9, 2020
Primary Completion Date
April 30, 2022
Study Completion Date
July 20, 2022
Eribulin Mesylate
Eribulin mesylate injection is performed on Day 1 and Day 8 of each treatment cycle (21 days per cycle). Patients were treated for six cycles, except disease progression (PD) or treatment stop for other reasons, such as severe adverse effects.
Anlotinib
12 mg Anlotinib is administered for continuous 14 days in 21 day cycles. Patients received Anlotinib untill disease progression.
Hunan Cancer Hospital, Changsha
Hunan Cancer Hospital
OTHER